Related references
Note: Only part of the references are listed.Reduced hydrophobicity of the colonic mucosal surface in ulcerative colitis as a hint at a physicochemical barrier defect
Annika Braun et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2011)
TNF-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells
Irina Treede et al.
BMC GASTROENTEROLOGY (2009)
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
H. Fidder et al.
GUT (2009)
Alterations of Phospholipid Concentration and Species Composition of the Intestinal Mucus Barrier in Ulcerative Colitis: A Clue to Pathogenesis
Annika Braun et al.
INFLAMMATORY BOWEL DISEASES (2009)
Serious Events with Infliximab in Patients with Inflammatory Bowel Disease A 9-Year Cohort Study in the Netherlands
Hilbert S. de Vries et al.
DRUG SAFETY (2008)
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
E. F. Stange et al.
JOURNAL OF CROHNS & COLITIS (2008)
Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches
Peter Lane
PHARMACEUTICAL STATISTICS (2008)
Phosphatidylcholine for steroid-refractory chronic ulcerative colitis - A randomized trial
Wolfgang Stremmel et al.
ANNALS OF INTERNAL MEDICINE (2007)
Anti-inflammatory effects of phosphatidylcholine
Irina Treede et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The quantitative validation of non-endoscopic disease activity indices in ulcerative colitis
P. D. R. Higgins et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years
Ole Hoie et al.
GASTROENTEROLOGY (2007)
Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis
W Stremmel et al.
GUT (2005)
Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis
PDR Higgins et al.
GUT (2005)
Is endoscopy necessary for the measurement of disease activity in ulcerative colitis?
PDR Higgins et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoelectrospray-tandem mass spectrometry
R Ehehalt et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences
EV Loftus
GASTROENTEROLOGY (2004)
Hepatitis A virus VP3 may activate serum response element associated transcription
T Kanda et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2003)
Defining relapse of ulcerative colitis using a symptom-based activity index
SL Jowett et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2003)
Inflammatory bowel disease
DK Podolsky
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
